| Literature DB >> 33105792 |
Sara Bom1,2, Manuel Fitas2, Ana Margarida Martins1, Pedro Pinto1,2, Helena Margarida Ribeiro1, Joana Marto1.
Abstract
With the increasing debate on sustainability, there is a strong market trend to formulate more sustainable products for topical application. Several studies emphasize the potential applications of natural, organic, or green chemistry-derived ingredients, but comparative studies between conventional ingredients and sustainable alternatives are lacking. This type of study is considered an excellent baseline and time-saving strategy for future studies. In addition, one of the main challenges of replacing ingredients by sustainable alternatives in topical vehicles is to maintain high-quality products. Thus, the main goal of this research study was to create a well-defined strategy supported by specific experimental data for the development of sustainable topical vehicles with high-quality standards. The study was designed to evaluate the effects of replacing conventional ingredients (e.g., hydrocarbons, silicones, and preservatives) by sustainable ones on the physical, chemical, and microbiological features of topical emulsions. Additionally, in vivo assessment studies were performed to evaluate the safety, biological efficacy, and sensorial aspects of the developed formulations. The results obtained showed that the replacement of ingredients by sustainable alternatives has an effective impact on the physicochemical and structural properties of the emulsions, mainly on their rheological behavior. However, using appropriate strategies for ingredient selection and rheological adjustment, it is possible to overcome some barriers created by the use of natural raw materials, thus developing appealing and high-quality sustainable topical vehicles.Entities:
Keywords: raw materials; replacement; sustainable; synthetic; topical application
Mesh:
Substances:
Year: 2020 PMID: 33105792 PMCID: PMC7660047 DOI: 10.3390/molecules25214887
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Description of the selected petrolatum, dimethicone, and phenoxyethanol alternatives.
| Petrolatum Alternatives | Dimethicone Alternatives | Phenoxyethanol Alternatives | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| INCI Name | Commercial Name and Abbreviature | Ingredient Category | INCI Name | Commercial Name and Abbreviature | Ingredient Category | INCI Name | Commercial Name and Abbreviature | Ingredient Category | ||
| Natural Vaseline® Type A (NVA) | Petrolatum-like ingredient | Octyldodecyl myristate | MOD (MD) | High viscosity | Benzyl alcohol, Salicylic acid, Glycerin, Sorbic acid | Geogard® ECT (GE) | Cosmetic preservatives | |||
|
| Massocare® Shea Butter (SB) | Semi-solid butters | ||||||||
| Hydrogenated olive oil, | Premium Organic Olive Butter® (OB) | Hydrogenated polysobutene | Vitabiosol S (SQ) | Sodium benzoate, Potassium sorbate | Sensicare® C 2010 (SC2) | |||||
| Lemon Butter® (LB) | ||||||||||
| Mango Butter Ultra® (MB) | Hydrogenated ethylhexyl olivate, Hydrogenated olive oil unsaponifiables | Natura-Tec® Plantsil (PLS) | Medium viscosity | Dehydroacetic acid, Benzyl alcohol | Sensicare® C 3000 (SC3) | |||||
| Kahl® Vego Jelly 7036 PLUS (KV) | Jelly-like/Blend ingredients | |||||||||
| Organic Jelly 7236 (OJ) | Propylene glycol dipelargonate | DPPG CG (DPPG) | Low viscosity | Gluconolactone, Sodium benzoate | Geogard Ultra™ (GU) | |||||
| PEG-8 Beeswax | Apifil® (AP) | Wax-like ingredient | ||||||||
| Glyceryl dibehenate, Tribehenin, Glyceryl behenate | Compritol® CG 888 Pellets (CM) | Blend ingredients | C15-19 Alkane | Emogreen™ L15 (EMG) | Sorbic acid | (SA) | Food preservatives | |||
| C10-18 Triglycerides | Lipocire™ A SG (LPC) | |||||||||
| Jojoba esters, | Acticire® MB (AC) | Sodium benzoate | (SOB) | |||||||
INCI: International Nomenclature of Cosmetic Ingredient.
Figure 1(a) Droplet size distribution of lab scale (F1 and F2) and pilot lab scale (F1s and F2s) formulations after manufacturing; n = 6; (b) Droplet size distribution of formulation F1s at the three different evaluation time points and storage conditions; n = 6; (c) Droplet size distribution of formulation F2s at the three different evaluation time points and storage conditions; n = 6.
Figure 2(a) Viscosity flow behavior of lab scale (F1 and F2) and pilot lab scale (F1s and F2s) formulations after manufacturing, and (b) viscoelastic behavior of lab-scale emulsions (F1 and F2).
Adhesive properties at 25 °C and 32 °C (mean ± SD, n = 6) and spreadability properties of the formulations (mean ± SD, n = 3).
| Formulation | Peak Normal Force (N) | Time for Force to Reduce by 90% of Peak(s) | Area under Force Time Curve (N.s) | Diameter of Spread Area (mm) |
|---|---|---|---|---|
| 25 °C | ||||
| Control | −0.70 ± 0.13 | −0.070 ± 0.013 | 1.83 ± 0.17 | 41.0 ± 0.0 |
| F1 | −0.78 ± 0.15 | −0.078 ± 0.015 | 1.38 ± 0.35 | 45.3 ± 0.6 |
| F2 | −1.30 ± 0.35 | −0.130 ± 0.035 | 2.62 ± 0.60 | 40.7 ± 0.6 |
| 32 °C | ||||
| Control | −0.57 ± 0.10 | −0.057 ± 0.010 | 3.10 ± 0.31 | - |
| F1 | −0.60 ± 0.05 | −0.060 ± 0.005 | 4.31 ± 0.12 | - |
| F2 | −0.63 ± 0.02 | −0.063 ± 0.002 | 4.82 ± 0.25 | - |
Stability test results for formulation F1s and F2s during 3 months at (25 ± 2) °C, at (40 ± 2) °C/(75 ± 5)% relative humidity (RH), and 25 °C (in-use).
| Formulation | Conditions of Storage | 25 °C | 25 °C (In-Use) | 40 °C | |||
|---|---|---|---|---|---|---|---|
| Time (Months) | pH Value | Viscosity (Pa.s) * | pH Value | Viscosity (Pa.s) * | pH Value | Viscosity (Pa.s) * | |
| F1s | 0 | 5.64 | 15.56 | 5.65 | 15.56 | 5.65 | - |
| 1 | 5.64 | 11.32 | 5.72 | 12.64 | 5.72 | 11.64 | |
| 3 | 5.64 | 13.88 | 5.65 | 18.65 | 5.80 | 11.41 | |
| F2s | 0 | 5.70 | 32.32 | 5.70 | 32.32 | 5.70 | - |
| 1 | 5.70 | 18.34 | 5.66 | 21.29 | 5.75 | 16.86 | |
| 3 | 5.70 | 20.62 | 5.71 | 20.46 | 5.86 | 22.18 | |
* Apparent viscosity at 2.155 s−1.
Figure 3Skin hydration results using the Corneometer and MoistureMap MM 100 devices. (a) Corneometry results over time (n = 9 ± SD). (b) Corneometry index variation vs. D0 (%). (c) Mean grey level (MGL) results over time (n = 9 ± SD). (d) MGL index variation vs. D0 (%).
Figure 4(a) Hydration images of the skin on the volar side of the forearm of one of the volunteers extracted from the MoistureMap MM 100 device before and after application. (b) Sensory profiles. In vivo assays (n = 9). (c) Macroscopic aspect of the validated formulations and control.
Figure 5Validation and/or exclusion diagram considering the physicochemical features of O/W emulsions.